The National Health Service (NHS) of England has announced that children in England will no longer be prescribed puberty blockers, except for those participating in clinical research trials. Private practices still offer this treatment. Puberty blockers delay the onset of puberty by inhibiting the body’s production of sex hormones, such as testosterone and oestrogen. While these hormonal suppressants don’t reverse existing changes, they can prevent further physical developments like breast growth and facial hair.
How do you think this decision might impact access to care for transgender and gender-nonconforming youth in England?